A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival

Blood

Volumn 102, Issue 7, 2003, Pages 2506-2512

  Cohen Saidon, Cellina ^c   Nechushtan, Hovav ^c   Kahlon, Shira ^c   Livni, Nadav ^c   Nissim, Ahuva ^b   Razin, Ehud ^a  

^a HEBREW UNIVERSITY   (Israel)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCL 2 ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY LIBRARY; ANTIGEN BINDING; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MAST CELL; MAST CELL LEUKEMIA; MEMBRANE TRANSPORT; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; RAT; SEQUENCE HOMOLOGY;

EID: 0141816702     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3921     Document Type: Article

References (26)

1. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci. 2001;26:61-66.
2. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
3. Rowan S, Fisher DE. Mechanisms of apoptotic cell death. Leukemia. 1997;11:457-465.
4. Reed JC, Miyashita T, Takayama S, et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem. 1996;60:23-32.
5. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
6. Reed JC. Mechanisms of apoptosis. Am J Pathol. 2000;157:1415-1430.
7. Mekori YA, Gilfillan AM, Akin C, Hartmann K, Metcalfe DD. Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol. 2001;21:171-174.
8. Cervero C, Escribano L, San Miguel JF, et al. Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. Am J Hematol. 1999;60:191-195.
9. Xiang Z, Ahmed AA, Moller C, et al. Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med. 2001;194:1561-1569.
10. Asai K, Kitaura J, Kawakami Y, et al. Regulation of mast cell survival by IgE. Immunity. 2001;14:791-800.
11. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol. 2000;18:989-994.
12. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315-1317.
13. Smothers JF, Henikoff S, Carter P. Phage display: affinity selection from biological libraries. Science. 2002;298:621-622.
14. Razin E, Cordon-Cardo C, Good RA. Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A. 1981;78:2559-2561.
15. Harrison JL, Williams SC, Winter G, Nissim A. Screening of phage antibody libraries. Methods Enzymol. 1996;267:83-109.
16. Nissim A, Hoogenboom HR, Tomlinson IM, et al. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J. 1994;13:692-698.
17. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997;272:16010-16017.
18. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol. 1994;12:433-455.
19. Hoogenboom HR, de Bruine AP, Hurten SE, et al. Antibody phage display technology and its applications. Immunotechnology. 1998;4:1-20.
20. Bonavia R, Bajetto A, Barbero S, et al. HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun. 2001;288:301-308.
21. Derossi D, Calvet S, Trembleau A, et al. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem. 1996;271:18188-18193.
22. Li Y, Rosal RV, Brandt-Rauf PW, Fine RL. Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide. Biochem Biophys Res Commun. 2002;298:439-449.
23. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 1994;369:321-323.
24. Sattler M, Liang H, Nettesheim D, et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 1997;275:983-986.
25. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 1996;56:1851-1854.
26. Maurer M, Tsai M, Metz M, et al. A role for Bax in the regulation of apoptosis in mouse mast cells. J Invest Dermatol. 2000;114:1205-1206.